4.7 Article

Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73

期刊

BLOOD
卷 112, 期 9, 页码 3856-3866

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2007-09-111773

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Pennsylvania Department of Health-sponsored Breast Cancer Research [41-000-37378]

向作者/读者索取更多资源

Down-regulation of the Kpm/Lats2 tumor suppressor is observed in various malignancies and associated with poor prognosis in acute lymphoblastic leukemia. We documented that Kpm/Lats2 was markedly decreased in several leukemias that were highly resistant to conventional chemotherapy. Silencing of Kpm/Lats2 expression in leukemic cells did not change the rate of cell growth but rendered the cells more resistant to DNA damage inducing agents. Expression of p21 and PUMA was strongly induced by these agents in control cells, despite defective p53, but was only slightly induced in Kpm/Lats2-knockdown cells. DNA damage induced nuclear accumulation of p73 was clearly observed in control cells but hardly detected in Kpm/Lats2-knockdown cells. Chromatin immunoprecipitation (ChIP) assay showed that p73 was recruited to the PUMA gene promoter in control cells but not in Kpm/Lats2-knockdown cells after DNA damage. The analyses with transient coexpression of Kpm/Lats2, YAP2, and p73 showed that Kpm/Lats2 contributed the stability of YAP2 and p73, which was dependent on the kinase function of Kpm/Lats2 and YAP2 phosphorylation at serine 127. Our results suggest that Kpm/Lats2 is involved in the fate of p73 through the phosphorylation of YAP2 by Kpm/Lats2 and the induction of p73 target genes that underlie chemosensitivity of leukemic cells. (Blood. 2008; 112:3856-3866)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation

Yuta Yamamoto, Takeru Makiyama, Takeshi Harita, Kenichi Sasaki, Yimin Wuriyanghai, Mamoru Hayano, Suguru Nishiuchi, Hirohiko Kohjitani, Sayako Hirose, Jiarong Chen, Fumika Yokoi, Taisuke Ishikawa, Seiko Ohno, Kazuhisa Chonabayashi, Hideki Motomura, Yoshinori Yoshida, Minoru Horie, Naomasa Makita, Takeshi Kimura

HUMAN MOLECULAR GENETICS (2017)

Article Cardiac & Cardiovascular Systems

Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation

Yimin Wuriyanghai, Takeru Makiyama, Kenichi Sasaki, Tsukasa Kamakura, Yuta Yamamoto, Mamoru Hayano, Takeshi Harita, Suguru Nishiuchi, Jiarong Chen, Hirohiko Kohjitani, Sayako Hirose, Fumika Yokoi, Jingshan Gao, Kazuhisa Chonabayashi, Ken Watanabe, Seiko Ohno, Yoshinori Yoshida, Takeshi Kimura, Minoru Horie

HEART RHYTHM (2018)

Article Cell & Tissue Engineering

Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients

Tadashi Takaki, Azusa Inagaki, Kazuhisa Chonabayashi, Keiji Inoue, Kenji Miki, Seiko Ohno, Takeru Makiyama, Minoru Horie, Yoshinori Yoshida

STEM CELLS INTERNATIONAL (2019)

Letter Hematology

Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis

Kazuhisa Chonabayashi, Yoshinori Yoshida, Toshio Kitawaki, Yasuhito Nannya, Momoko Nakamura, Shinichiro Oshima, Masakatsu Hishizawa, Kouhei Yamashita, Seishi Ogawa, Akifumi Takaori-Kondo

ANNALS OF HEMATOLOGY (2019)

Letter Hematology

Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab

Fumiya Wada, Tadakazu Kondo, Momoko Nakamura, Kazuhisa Chonabayashi, Momoko Nishikori, Masakatsu Hishizawa, Kouhei Yamashita, Akifumi Takaori-Kondo

ANNALS OF HEMATOLOGY (2020)

Correction Cell & Tissue Engineering

Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients (vol 2019, 7532657, 2019)

Tadashi Takaki, Azusa Inagaki, Kazuhisa Chonabayashi, Keiji Inoue, Kenji Miki, Seiko Ohno, Takeru Makiyama, Minoru Horie, Yoshinori Yoshida

STEM CELLS INTERNATIONAL (2020)

Article Hematology

A frequent nonsense mutation in exon 1 across certain HLA-A and HLA-B alleles in leukocytes of patients with acquired aplastic anemia

Hiroki Mizumaki, Kazuyoshi Hosomichi, Kohei Hosokawa, Takeshi Yoroidaka, Tatsuya Imi, Yoshitaka Zaimoku, Takamasa Katagiri, Mai Anh Thi Nguyen, Dung Cao Tran, Mahmoud Ibrahim Yousef Elbadry, Kazuhisa Chonabayashi, Yoshinori Yoshida, Hiroyuki Takamatsu, Tatsuhiko Ozawa, Fumihiro Azuma, Hiroyuki Kishi, Yoichi Fujii, Seishi Ogawa, Atsushi Tajima, Shinji Nakao

Summary: The research found that leukocytes lacking HLA alleles are common in patients with acquired aplastic anemia, possibly due to loss-of-function mutations in certain HLA-A or B alleles. A droplet digital polymerase chain reaction assay was able to accurately detect this mutation, which could serve as a powerful tool for diagnosing the immune pathophysiology of patients with bone marrow failure.

HAEMATOLOGICA (2021)

Article Cell Biology

Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model

Sayako Hirose, Takeru Makiyama, Dario Melgari, Yuta Yamamoto, Yimin Wuriyanghai, Fumika Yokoi, Suguru Nishiuchi, Takeshi Harita, Mamoru Hayano, Hirohiko Kohjitani, Jingshan Gao, Asami Kashiwa, Misato Nishikawa, Jie Wu, Jun Yoshimoto, Kazuhisa Chonabayashi, Seiko Ohno, Yoshinori Yoshida, Minoru Horie, Takeshi Kimura

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Oncology

The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β

Mikoto Tanabe, Kohei Hosokawa, Mai Anh Thi Nguyen, Noriharu Nakagawa, Kana Maruyama, Noriaki Tsuji, Ryota Urushihara, Luis Espinoza, Mahmoud Elbadry, Md Mohiuddin, Takamasa Katagiri, Masanori Ono, Hiroshi Fujiwara, Kazuhisa Chonabayashi, Yoshinori Yoshida, Hirohito Yamazaki, Atsushi Hirao, Shinji Nakao

Summary: CD109 suppresses TGF-beta signaling in HSPCs, and the lack of CD109 may increase the sensitivity of PIGA-mutated HSPCs to TGF-beta, leading to the preferential commitment of erythroid progenitor cells to mature red blood cells in immune-mediated BM failure.

LEUKEMIA (2022)

Article Hematology

Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia

Yuki Morimoto, Kazuhisa Chonabayashi, Hiroshi Kawabata, Chikako Okubo, Makiko Yamasaki-Morita, Misato Nishikawa, Megumi Narita, Azusa Inagaki, Kayoko Nakanishi, Miki Nagao, Akifumi Takaori-Kondo, Yoshinori Yoshida

Summary: This study successfully generated wild-type and mutant ALAS2-induced pluripotent stem cell (iPSC) lines from the peripheral blood cells of a family with pyridoxine-resistant X-linked sideroblastic anemia (XLSA) caused by a missense mutation in the ALAS2 gene. The mutant iPSC lines showed impaired erythroid differentiation potential, immature morphological phenotype, and dysplasia in erythroblasts. Treatment with delta-aminolevainic acid improved the erythroid differentiation ability and hemoglobin expression of mutant iPSC-derived hematopoietic progenitor cells (HPCs). Furthermore, the DNA demethylating agent azacitidine reactivated the silent wild-type ALAS2 allele and improved erythroid differentiation defects in mutant HPCs.

BLOOD ADVANCES (2022)

Article Cell & Tissue Engineering

Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting

Yuta Tsujisaka, Takeshi Hatani, Chikako Okubo, Ryo Ito, Azuma Kimura, Megumi Narita, Kazuhisa Chonabayashi, Shunsuke Funakoshi, Antonio Lucena-Cacace, Taro Toyoda, Kenji Osafune, Takeshi Kimura, Hirohide Saito, Yoshinori Yoshida

Summary: By combining miR-switch with MACS technology, we have developed a rapid and efficient method for purifying large amounts of PSC-derived cells. This method can detect specific miRNAs in target cells and use CD4 transgene as a selection marker for MACS, achieving cell purification.

STEM CELL REPORTS (2022)

Article Cardiac & Cardiovascular Systems

Disrupted CaV1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in the CACNA1C-E1115K iPS cell model

Asami Kashiwa, Takeru Makiyama, Hirohiko Kohjitani, Thomas L. Maurissen, Taisuke Ishikawa, Yuta Yamamoto, Yimin Wuriyanghai, Jingshan Gao, Hai Huang, Tomohiko Imamura, Takanori Aizawa, Misato Nishikawa, Kazuhisa Chonabayashi, Hiroyuki Mishima, Seiko Ohno, Futoshi Toyoda, Seiichi Sato, Koh-Ichiro Yoshiura, Kazuhiro Takahashi, Yoshinori Yoshida, Knut Woltjen, Minoru Horie, Naomasa Makita, Takeshi Kimura

Summary: This study investigated the electrophysiological features and pathophysiological mechanisms of the CACNA1C-E1115K mutation using patient-specific induced pluripotent stem cell-derived cardiomyocytes. The mutant cells exhibited impaired calcium current, changes in action potential, and the occurrence of arrhythmia. Evaluation of drug treatment showed that specific antiarrhythmic drugs could shorten the action potential of the mutant cells by modulating the upregulation of sodium current (I-NaL). In conclusion, this study revealed the role of the CACNA1C-E1115K mutation in arrhythmia and provided insights into its underlying mechanisms.

HEART RHYTHM (2023)

Correction Hematology

Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack (vol 2, pg 390, 2018)

J. Luis Espinoza, Mahmoud I. Elbadry, Kazuhisa Chonabayashi, Yoshinori Yoshida, Takamasa Katagiri, Kenichi Harada, Noriharu Nakagawa, Yoshitaka Zaimoku, Tatsuya Imi, Hiroyuki Takamatsu, Tatsuhiko Ozawa, Hiroyuki Maruyama, Hassan A. Hassanein, Amal Khalifa A. Noreldin, Katsuto Takenaka, Koichi Akashi, Hiroshi Hamana, Hiroyuki Kishi, Yoshiki Akatsuka, Shinji Nakao

BLOOD ADVANCES (2018)

Article Hematology

Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack

J. Luis Espinoza, Mahmoud I. Elbadry, Kazuhisa Chonabayashi, Yoshinori Yoshida, Takamasa Katagiri, Kenichi Harada, Noriharu Nakagawa, Yoshitaka Zaimoku, Tatsuya Imi, Hassan A. Hassanein, Amal Khalifa A. Noreldin, Katsuto Takenaka, Koichi Akashi, Hiroshi Hamana, Hiroyuki Kishi, Yoshiki Akatsuka, Shinji Nakao

BLOOD ADVANCES (2018)

Article Cardiac & Cardiovascular Systems

Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy

Mamoru Hayano, Takeru Makiyama, Tsukasa Kamakura, Hiroshi Watanabe, Kenichi Sasaki, Shunsuke Funakoshi, Yimin Wuriyanghai, Suguru Nishiuchi, Takeshi Harita, Yuta Yamamoto, Hirohiko Kohjitani, Sayako Hirose, Fumika Yokoi, Jiarong Chen, Osamu Baba, Takahiro Horie, Kazuhisa Chonabayashi, Seiko Ohno, Futoshi Toyoda, Yoshinori Yoshida, Koh Ono, Minoru Horie, Takeshi Kimura

CIRCULATION JOURNAL (2017)

暂无数据